These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8779143)

  • 1. Lung bioavailability of generic and innovator salbutamol metered dose inhalers.
    Clark DJ; Gordon-Smith J; McPhate G; Clark G; Lipworth BJ
    Thorax; 1996 Mar; 51(3):325-6. PubMed ID: 8779143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumatic usage: some generic salbutamol metered dose inhalers can be used.
    Chege JK; Chrystyn H
    Thorax; 1994 Nov; 49(11):1162-3. PubMed ID: 7831635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
    Hindle M; Chrystyn H
    Thorax; 1994 Jun; 49(6):549-53. PubMed ID: 8016791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.
    Clark DJ; Lipworth BJ
    Thorax; 1996 Oct; 51(10):981-4. PubMed ID: 8977596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Salamol less effective than Ventolin? A randomised, blinded, crossover study in New Zealand.
    Chang CL; Cooray M; Mills G; Hancox RJ
    N Z Med J; 2007 Dec; 120(1267):U2874. PubMed ID: 18157200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.
    Silkstone VL; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2002 Aug; 54(2):115-9. PubMed ID: 12207629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design.
    Ammari WG; Oriquat GA; Sanders M
    Eur J Pharm Sci; 2020 Apr; 147():105304. PubMed ID: 32165316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic inhaled salbutamol versus branded salbutamol. A randomised double-blind study.
    Williamson IJ; Reid A; Monie RD; Fennerty AG; Rimmer EM
    Postgrad Med J; 1997 Mar; 73(857):156-8. PubMed ID: 9135831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of in vivo bioequivalence of a generic albuterol metered-dose inhaler to Ventolin.
    Stewart BA; Ahrens RC; Carrier S; Frosolono M; Lux C; Han SH; Milavetz G
    Chest; 2000 Mar; 117(3):714-21. PubMed ID: 10712996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol.
    Clark DJ; Lipworth BJ
    Br J Clin Pharmacol; 1996 Mar; 41(3):247-9. PubMed ID: 8866927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.
    Hindle M; Newton DA; Chrystyn H
    Thorax; 1993 Jun; 48(6):607-10. PubMed ID: 8346489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler.
    Hindle M; Peers EM; Parry-Billings M; Chrystyn H
    Br J Clin Pharmacol; 1997 Mar; 43(3):336-8. PubMed ID: 9088593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of innovator and generic salbutamol inhalers: a double-blind randomized study of efficacy and tolerance.
    Pinto Pereira LM; Clement YN; Pinto Pereira SM
    Int J Clin Pharmacol Res; 2002; 22(3-4):73-80. PubMed ID: 12837043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilating effects of salbutamol from a novel inhaler Airmax.
    Middle MV; Terblanché J; Perrin VL; Hertog MG
    Respir Med; 2002 Jul; 96(7):493-8. PubMed ID: 12194632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative Lung and Systemic Bioavailability Along with Oropharyngeal Deposition of Salbutamol Post-Inhalation: A Pharmacokinetic Evaluation of Novel Inhaler Technique Training Gadgets.
    Ammari WG; Sanders M
    J Aerosol Med Pulm Drug Deliv; 2022 Oct; 35(5):278-285. PubMed ID: 35984934
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Eur J Clin Pharmacol; 1997; 53(1):47-9. PubMed ID: 9349929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.